Abstract | BACKGROUND: METHODS: In a randomized, double-blind, placebo-controlled trial, 120 female patients received granisetron 40 micrograms.kg-1, droperidol 1.25 mg, metoclopramide 10 mg or placebo (saline) ( n = 30 for each) intravenously immediately before the induction of anaesthesia. A standard general anaesthetic technique was employed throughout. Postoperatively, during the first 24 h after anaesthesia, the incidence of PONV and adverse events was recorded. RESULTS: The incidence of PONV was 17% with granisetron, 37% with droperidol, 43% with metoclopramide and 50% with placebo (P < 0.05; overall Fisher's exact probability test). The incidence of adverse events was not different among the groups. CONCLUSION:
|
Authors | Y Fujii, H Tanaka, H Toyooka |
Journal | Acta anaesthesiologica Scandinavica
(Acta Anaesthesiol Scand)
Vol. 42
Issue 2
Pg. 220-4
(Feb 1998)
ISSN: 0001-5172 [Print] England |
PMID | 9509207
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Retracted Publication)
|
Chemical References |
- Antiemetics
- Metoclopramide
- Droperidol
- Granisetron
|
Topics |
- Adult
- Antiemetics
(therapeutic use)
- Breast Neoplasms
(surgery)
- Double-Blind Method
- Droperidol
(therapeutic use)
- Female
- Granisetron
(therapeutic use)
- Humans
- Metoclopramide
(therapeutic use)
- Middle Aged
- Nausea
(prevention & control)
- Postoperative Complications
(prevention & control)
- Vomiting
(prevention & control)
|